Millipore Sigma Vibrant Logo

579000 Tamoxifen Citrate - CAS 54965-24-1 - Calbiochem

Tamoxifen is a potent synthetic anti-estrogenic agent.

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: Estrogen Receptor Signaling Regulator I

Primary Target: PKC
View Products on Sigmaaldrich.com
579000
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
54965-24-1C₂₆H₂₉NO · C₆H₈O₇

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
579000-100MG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Flacon en verre 100 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewA potent synthetic anti-estrogenic agent. A cell-permeable and reversible inhibitor of protein kinase C (IC50 = 10 µM). Induces apoptosis in human malignant glioma cell lines and inhibits prostate cancer cell growth by induction of p21 protein.
      Catalogue Number579000
      Brand Family Calbiochem®
      SynonymsEstrogen Receptor Signaling Regulator I
      References
      ReferencesRohlff, C., et al. 1998. Prostate 37, 51.
      Couldwell, W.J., et al. 1994. FEBS Lett. 345, 43.
      Baltuch, G.H., et al. 1993. Neurosurgery 33, 495.
      Powis, G. 1991. Trends Pharmacol. Sci. 12, 188.
      Issandou, M., et al. 1990. Cancer Res. 50, 5845.
      O’Brian, C.A., et al. 1985. Cancer Res. 45, 2462.
      Product Information
      CAS number54965-24-1
      ATP CompetitiveN
      FormWhite to off-white powder
      Hill FormulaC₂₆H₂₉NO · C₆H₈O₇
      Chemical formulaC₂₆H₂₉NO · C₆H₈O₇
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPKC
      Primary Target IC<sub>50</sub>10 µM against protein kinase C
      Purity≥99% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSKH2387000
      Safety Information
      R PhraseR: 22-45-60-61-64

      Harmful if swallowed.
      May cause cancer.
      May impair fertility.
      May cause harm to the unborn child.
      May cause harm to breastfed babies.
      S PhraseS: 36/37/39-45

      Wear suitable protective clothing, gloves and eye/face protection.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful & Carcinogenic / Teratogenic
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      579000-100MG 04055977265934

      Documentation

      Tamoxifen Citrate - CAS 54965-24-1 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Tamoxifen Citrate - CAS 54965-24-1 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      579000

      Références bibliographiques

      Aperçu de la référence bibliographique
      Rohlff, C., et al. 1998. Prostate 37, 51.
      Couldwell, W.J., et al. 1994. FEBS Lett. 345, 43.
      Baltuch, G.H., et al. 1993. Neurosurgery 33, 495.
      Powis, G. 1991. Trends Pharmacol. Sci. 12, 188.
      Issandou, M., et al. 1990. Cancer Res. 50, 5845.
      O’Brian, C.A., et al. 1985. Cancer Res. 45, 2462.

      Brochure

      Titre
      Caspases and other Apoptosis Related Tools Brochure
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision11-January-2010 RFH
      SynonymsEstrogen Receptor Signaling Regulator I
      DescriptionA potent synthetic anti-estrogen. A cell-permeable and reversible inhibitor of protein kinase C (IC50 = 10 µM). Induces apoptosis in human malignant glioma cell lines.
      FormWhite to off-white powder
      CAS number54965-24-1
      RTECSKH2387000
      Chemical formulaC₂₆H₂₉NO · C₆H₈O₇
      Structure formulaStructure formula
      Purity≥99% by HPLC
      SolubilityEthanol (5 mg/ml), Methanol (5 mg/ml), or sparingly soluble in H₂O
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Harmful & Carcinogenic / Teratogenic
      Merck USA index14, 9048
      ReferencesRohlff, C., et al. 1998. Prostate 37, 51.
      Couldwell, W.J., et al. 1994. FEBS Lett. 345, 43.
      Baltuch, G.H., et al. 1993. Neurosurgery 33, 495.
      Powis, G. 1991. Trends Pharmacol. Sci. 12, 188.
      Issandou, M., et al. 1990. Cancer Res. 50, 5845.
      O’Brian, C.A., et al. 1985. Cancer Res. 45, 2462.